Your browser doesn't support javascript.
loading
Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.
Nishizawa, Daisuke; Kasai, Shinya; Hasegawa, Junko; Sato, Naomi; Yamada, Hidetaka; Tanioka, Fumihiko; Nagashima, Makoto; Katoh, Ryoji; Satoh, Yasuo; Tagami, Megumi; Ujike, Hiroshi; Ozaki, Norio; Inada, Toshiya; Iwata, Nakao; Sora, Ichiro; Iyo, Masaomi; Yamada, Mitsuhiko; Kondo, Naoki; Won, Moo-Jun; Naruse, Nobuya; Uehara-Aoyama, Kumi; Itokawa, Masanari; Ohi, Kazutaka; Hashimoto, Ryota; Tanisawa, Kumpei; Arai, Tomio; Mori, Seijiro; Sawabe, Motoji; Naka-Mieno, Makiko; Yamada, Yoshiji; Yamada, Miki; Sato, Noriko; Muramatsu, Masaaki; Tanaka, Masashi; Irukayama-Tomobe, Yoko; Saito, Yuki C; Sakurai, Takeshi; Hayashida, Masakazu; Sugimura, Haruhiko; Ikeda, Kazutaka.
Afiliação
  • Nishizawa D; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. nishizawa-ds@igakuken.or.jp.
  • Kasai S; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. kasai-sy@igakuken.or.jp.
  • Hasegawa J; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. hasegawa-jk@igakuken.or.jp.
  • Sato N; Department of Clinical Nursing, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. naomi25@hama-med.ac.jp.
  • Yamada H; Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. naomi25@hama-med.ac.jp.
  • Tanioka F; Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. h-yamada@hama-med.ac.jp.
  • Nagashima M; Department of Pathology, Iwata City Hospital, Iwata, 438-8550, Japan. kyon8@juno.ocn.ne.jp.
  • Katoh R; Department of Surgery, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. nagashima@sakura.med.toho-u.ac.jp.
  • Satoh Y; Department of Surgery, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. ryochan@sakura.med.toho-u.ac.jp.
  • Tagami M; Department of Anesthesiology, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. satoh-ane@sakura.med.toho-u.ac.jp.
  • Ujike H; Department of Anesthesiology, Toho University Sakura Medical Center, Sakura, 285-8741, Japan. tagami@sakura.med.toho-u.ac.jp.
  • Ozaki N; Ujike Nishiguchi Clinic, Okayama, 700-0024, Japan. hujike-10@t.okadai.jp.
  • Inada T; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. hujike-10@t.okadai.jp.
  • Iwata N; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. ozaki-n@med.nagoya-u.ac.jp.
  • Sora I; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. ozaki-n@med.nagoya-u.ac.jp.
  • Iyo M; Department of Psychiatry, Seiwa Hospital, Institute of Neuropsychiatry, Tokyo, 162-0851, Japan. inada@seiwa-hp.com.
  • Yamada M; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. inada@seiwa-hp.com.
  • Kondo N; Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, 470-1192, Japan. nakao@fujita-hu.ac.jp.
  • Won MJ; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. nakao@fujita-hu.ac.jp.
  • Naruse N; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. sora@med.kobe-u.ac.jp.
  • Uehara-Aoyama K; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan. sora@med.kobe-u.ac.jp.
  • Itokawa M; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. sora@med.kobe-u.ac.jp.
  • Ohi K; Department of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, 260-8670, Japan. iyom@faculty.chiba-u.jp.
  • Hashimoto R; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. iyom@faculty.chiba-u.jp.
  • Tanisawa K; Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, 187-8553, Japan. mitsu@ncnp-k.go.jp.
  • Arai T; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. mitsu@ncnp-k.go.jp.
  • Mori S; Seimei Hospital, Fuji City, 417-0801, Japan. waveonlyjust@yahoo.co.jp.
  • Sawabe M; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. waveonlyjust@yahoo.co.jp.
  • Naka-Mieno M; Koujin Hospital, Nagoya, 463-8530, Japan. wonmj@hm10.aitai.ne.jp.
  • Yamada Y; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. wonmj@hm10.aitai.ne.jp.
  • Yamada M; Saitama Seishin-iryo Center, Kita-adachi, Saitama, 362-0806, Japan. naruse.nobuya@pref.saitama.lg.jp.
  • Sato N; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. naruse.nobuya@pref.saitama.lg.jp.
  • Muramatsu M; Kanagawa Psychiatric Center, Serigaya Hospital, Kanagawa, 233-0006, Japan. kums@ballade.plala.or.jp.
  • Tanaka M; Japanese Genetics Initiative for Drug Abuse (JGIDA), Tokyo, Japan. kums@ballade.plala.or.jp.
  • Irukayama-Tomobe Y; Schizophrenia and Depression Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, 156-8506, Japan. itokawa-ms@igakuken.or.jp.
  • Saito YC; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan. ohi@psy.med.osaka-u.ac.jp.
  • Sakurai T; National Hospital Organization, Yamato Mental-Medical Center, Nara, 639-1042, Japan. ohi@psy.med.osaka-u.ac.jp.
  • Hayashida M; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan. hashimor@psy.med.osaka-u.ac.jp.
  • Sugimura H; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University, Chiba University, and Fukui University School of Medicine, Osaka, 565-0871, Japan. hashimor@psy.med.osaka-u.ac.jp.
  • Ikeda K; Department of Genomics for Longevity and Health, Tokyo Metropolitan Institute of Gerontology, Tokyo, 173-0015, Japan. kunpei-tanisawa@fuji.waseda.jp.
Mol Brain ; 8: 50, 2015 Aug 20.
Article em En | MEDLINE | ID: mdl-26289589
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tabagismo / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Estudo de Associação Genômica Ampla / Receptores de Orexina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tabagismo / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Estudo de Associação Genômica Ampla / Receptores de Orexina Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article